Skip to main content
. 2014 Jan 30;1(1):57–68. doi: 10.18632/oncoscience.9

Table 2. Resistant clones harboring a BCR-ABL1-KD mutation.

Exp. TKI UT-7 cell line MS-5 feeder Clones tested for mutation Results of mutation analysis
Number Available** No mutation one mutation two mutations
1 imatinib UT-7-11 24 22 2 20 0
+ 24 23 0 23 0
2 nilotinib UT-7-11 24 24 11 12 1
+ 24* 24 13 11 0
3 dasatinib UT-7-11 12 12 1 11 0
+ 11 11 1 10 0
4 ponatinib UT-7-315 48 47 0 10*** 37****
+ 48 46 0 34*** 12****
5 ponatinib UT-7-11 0 0 0 0 0
+ 24 24 0 22*** 2****
*

Methylcellulose colonies after 14 days of culture in the presence of nilotinib.

**

Clones correctly expanded in 24-well plates.

***

T315I mutation alone.

****

one mutation in addition to the T315I mutation.